Pierre-Alain Andre
Overview
Explore the profile of Pierre-Alain Andre including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
84
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pilyugin M, Descloux P, Andre P, Laszlo V, Dome B, Hegedus B, et al.
PLoS One
. 2017 Aug;
12(8):e0182356.
PMID: 28786985
Purpose: Currently the screening for lung cancer for risk groups is based on Computed Tomography (CT) or low dose CT (LDCT); however, the lung cancer death rate has not decreased...
2.
Pilyugin M, Andre P, Ratajska M, Kuzniacka A, Limon J, Tournier B, et al.
Oncotarget
. 2016 Dec;
8(6):9339-9353.
PMID: 28030839
Previous reports have shown that expression of BARD1δ, a deletion-bearing isoform of BARD1, correlates with tumor aggressiveness and progression. We show that expression of BARD1δ induces cell cycle arrest in...
3.
Andre P, Prele C, Vierkotten S, Carnesecchi S, Donati Y, Chambers R, et al.
Respir Res
. 2015 Sep;
16:118.
PMID: 26415510
Background: Idiopathic pulmonary fibrosis (IPF) is a rapid progressive fibro-proliferative disorder with poor prognosis similar to lung cancer. The pathogenesis of IPF is uncertain, but loss of epithelial cells and...
4.
Zhang Y, Bianco A, Malkinson A, Leoni V, Frau G, Rosa N, et al.
Int J Cancer
. 2011 Aug;
131(1):83-94.
PMID: 21815143
BRCA1 mRNA overexpression is correlated with poor survival in NSCLC. However, BRCA1 functions depend on the interaction with BARD1 for its stability, nuclear localization and ubiquitin ligase activity. Expression of...
5.
Loisel S, Andre P, Golay J, Buchegger F, Kadouche J, Cerutti M, et al.
Mol Cancer
. 2011 Apr;
10:42.
PMID: 21504579
Background: The increasing availability of different monoclonal antibodies (mAbs) opens the way to more specific biologic therapy of cancer patients. However, despite the significant success of therapy in breast and...
6.
Golay J, Bologna L, Andre P, Buchegger F, Mach J, Boumsell L, et al.
Blood
. 2010 Oct;
116(17):3372-3.
PMID: 21030571
No abstract available.
7.
Viertl D, Bischof Delaloye A, Lanz B, Poitry-Yamate C, Gruetter R, Mlynarik V, et al.
Mol Imaging Biol
. 2010 Jun;
13(2):321-31.
PMID: 20556524
Purpose: 3'-deoxy-3'-[(18)F]fluorothymidine ([(18)F]FLT), a cell proliferation positron emission tomography (PET) tracer, has been shown in numerous tumors to be more specific than 2-deoxy-2-[(18)F]fluoro-D-glucose ([(18)F]FDG) but less sensitive. We studied the...